Table 5.
Analysis of factors associated with recurrence or exacerbation of uveitis.
| Variables (reference value) |
Univariate analysis | Multifactor regression analysis |
|||
|---|---|---|---|---|---|
| OR (95%) | P | OR (95%) | P | ||
| Gender (Female) | 2.245(0.822-6.130) | 0.114 | |||
| Age | 1.013(0.988-1.038) | 0.310 | |||
|
Smoking history
(No history of smoking) |
Quit smoking | 0.507(0.058-4.437) | 0.540 | ||
| Still smoking | 0.830(0.213-3.236) | 0.788 | |||
|
Eyes with uveitis
(Bilateral) |
1.107(0.445-2.758) | 0.827 | |||
|
Duration of uveitis
(less than 5 years) |
5 to 10 years | 1.017(0.328-3.151) | 0.977 | ||
| Over 10 years | 0.555(0.113-2.717) | 0.467 | |||
| Systemic disease | 1.312(0.519-3.320) | 0.566 | |||
| Severity of COVID-19 infection (non-severe) | 2.632(0.943-7.345) | 0.065 | |||
| Ocular inflammatory activity before SARS-CoV-2 infection | 4.298(1.735-10.647) | 0.002 | 4.298(1.735-10.647) | 0.002 | |
| Use of glucocorticoids | 1.105(0.427-2.859) | 0.836 | |||
| Use of immunosuppressants | 1.571(0.615-4.-18) | 0.345 | |||
| Use of biological agents | 0.716(0.219-2.346) | 0.581 | |||
| Vaccination times (Zero) | One | / | / | ||
| Two | 0.641(0.171-2.405) | 0.510 | |||
| Three | 1.351(0.453-4.027) | 0.589 | |||
| Four | 0.833(0.078-8.947) | 0.880 | |||